Aryl Hydrocarbon Hydroxylase in a Stable Human B-Lymphocyte Cell Line, RPMI-1788, Cultured in the Absence of Mitogens1

A stable, immunologically defined human B-lymphocyte cell line (RPMI-1788) in a long-term culture has shown high basal and inducible aryl hydrocarbon hydroxylase (AHH) activity in the absence of mitogenic prestimulation, making it an excellent and a prolific source of human tissue for studies on human mixed-function oxygenases. Various parameters influencing the enzyme activity and inducibility were studied and optimized. This allowed attainment of enzyme levels and inducibility ratios comparable to those previously reported for fresh, mitogen-activated human lymphocytes. Dibenz(a,h)anthracene, at an optimal concentration of 0.3 /IM and an optimal exposure time of 24 hr, was 30 times more potent an inducer than 1,2-benzanthracene. Maximal basal and induced enzyme activities and cell viability occurred at 48 hr of culture while the cell viability frequently declined by 72 hr of culture. The mitogens, pnytohemagglutinin M (200 fig/ml) and concanavalin A (40 /ig/ml), which were not obligatory for AHH expression, en hanced AHH activity while, at the same time, decreasing the number of viable cells per culture. However, combinations of phytohemagglutinin and concanavalin A or those of either of these with pokeweed mitogen (itself ineffective) did not poten tiate AHH activity over that obtained with phytohemagglutinin or concanavalin A used alone; however, various mitogen com binations were more cytotoxic than individual mitogens. Lipopolysaccharide B did not affect either cell growth or AHH activity. Using cells cultured under optimal conditions and induced optimally with dibenz(a,/?)anthracene, metabolism of benzo(a)pyrene was analyzed by high-pressure liquid chromatography. The metabolite profile produced by these cells had several similarities with those produced by mitogen-stim-ulated, short-term cultured human lymphocytes derived from fresh blood and by rodent liver microsomes. from the felt that the differences between the basal and the induced AHH in less variable physical and enzymological properties than absolute AHH activity provide a useful qualitative method for the identification of AHH-inducible population from the noninducible population. This paper describes optimization of conditions for AHH activity and inducibility in a B-cell line (RPMI-1788) and characterizes the enzyme with respect to the profile of BP metabolites produced. RPMI-1788 is an immu-noglobulin-synthesizing B-lymphocyte cell line

[1]  D. Jerina,et al.  Arene oxides and the NIH shift: The metabolism, toxicity and carcinogenicity of aromatic compounds , 1972, Experientia.

[2]  J. Minowada,et al.  Induction, inhibition, and biological properties of aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788. , 1979, Cancer research.

[3]  B. Paigen,et al.  Induction, inhibition, and some enzymological properties of aryl hydrocarbon hydroxylase in fresh mitogen-activated human lymphocytes. , 1979, Cancer research.

[4]  B. Paigen,et al.  Comparison of benzo[a]pyrene metabolism by human peripheral blood lymphocytes and monocytes. , 1978, Cancer letters.

[5]  S. Orrenius,et al.  Fluorescence study of DNA-binding metabolites of benzo(a)pyrene formed in hepatocytes isolated from 3-methylcholanthrene-treated rats. , 1978, Cancer research.

[6]  W. Kalow,et al.  Seasonal variation of aryl hydrocarbon hydroxylase inducibility in human lymphocytes in culture. , 1978, Research communications in chemical pathology and pharmacology.

[7]  A. Boobis,et al.  Carcinogenic benzo(a)pyrene metabolites bound to DNA: metabolic formation by human cultured lymphocytes and by human liver microsomes. , 1978, Pharmacology.

[8]  B. Paigen,et al.  Factors influencing the measurement and the reproducibility of aryl hydrocarbon hydroxylase activity in culutred human lymphocytes. , 1977, Journal of the National Cancer Institute.

[9]  B. Paigen,et al.  Questionable relation of aryl hydrocarbon hydroxylase to lung-cancer risk. , 1977, The New England journal of medicine.

[10]  I. Bross,et al.  Distribution of aryl hydrocarbon hydroxylase inducibility in cultured human lymphocytes. , 1977, Cancer research.

[11]  D. Nebert,et al.  Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. , 1976, Cancer research.

[12]  D. Jerina,et al.  Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. , 1976, Cancer research.

[13]  R. Bast,et al.  Development of an assay for aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes. , 1976, Cancer research.

[14]  L. Sachs,et al.  Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Selkirk,et al.  Kinetic analysis of the metabolism of benzo(a)pyrene to phenols, dihydrodiols, and quinones by high-pressure chromatography compared to analysis by aryl hydrocarbon hydroxylase assay, and the effect of enzyme induction. , 1975, Cancer research.

[16]  J. Selkirk,et al.  In vitro metabolism of benzo(a)pyrene by human liver microsomes and lymphocytes. , 1975, Cancer research.

[17]  W. Caspary,et al.  Autoxidation of 6-hydroxybenzo(a)pyrene and 6-oxobenzo(a)pyrene radical, reactive metabolites of benzo(a)pyrene , 1975 .

[18]  J. Minowada,et al.  Properties, inducibility, and an improved method of analysis of aryl hydrocarbon hydroxylase in cultured human lymphocytes. , 1975, Cancer research.

[19]  H. Gurtoo,et al.  Hepatic microsomal mixed function oxygenase: enzyme multiplicity for the metabolism of carcinogens to DNA-binding metabolites. , 1974, Biochemical and biophysical research communications.

[20]  A. Hewer,et al.  Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide , 1974, Nature.

[21]  S. Epstein,et al.  Environmental determinants of human cancer. , 1974, Cancer research.

[22]  J. Booth,et al.  The metabolism of polycyclic hydrocarbons by cultured human lymphocytes , 1974, FEBS letters.

[23]  G. Moore,et al.  The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line. , 1974, Cancer research.

[24]  J. Selkirk,et al.  Benzo[a]pyrene Metabolites: Efficient and Rapid Separation by High-Pressure Liquid Chromatography , 1974, Science.

[25]  C R Shaw,et al.  Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. , 1973, The New England journal of medicine.

[26]  G. Warr,et al.  Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. , 1973, Transactions of the Association of American Physicians.

[27]  G. Kellermann,et al.  Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. , 1973, American journal of human genetics.

[28]  W. Benedict,et al.  Genetic differences in aryl hydrocarbon hydroxylase induction and benzo(a)pyrene-produced tumorigenesis in the mouse. , 1973, Molecular pharmacology.

[29]  D. Nebert,et al.  Genetic regulation of aryl hydrocarbon hydroxylase induction. V. Specific changes in spin state of cytochrome P 450 from genetically responsive animals. , 1973, The Journal of biological chemistry.

[30]  A. Y. Lu,et al.  Effect of enzyme inducers on substrate specificity of the cytochrome P-450's. , 1973, Drug metabolism and disposition: the biological fate of chemicals.

[31]  D. Nebert,et al.  Aryl hydrocarbon hydroxylase induction in mammalian liver cell culture. 3. Effects of various sera, hormones, biogenic amines, and other endogenous compounds on the enzyme activity. , 1972, The Journal of biological chemistry.

[32]  A. Y. Lu,et al.  Partial purification and properties of cytochromes P-450 and P-448 from rat liver microsomes. , 1972, Archives of biochemistry and biophysics.

[33]  D. Nebert,et al.  Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P-450 and the effect on benzo(a)pyrene metabolism in vitro. , 1972, Molecular pharmacology.

[34]  J. Whitlock,et al.  Aryl Hydrocarbon (Benzopyrene) Hydroxylase Is Stimulated in Human Lymphocytes by Mitogens and Benz[a]anthracene , 1972, Science.

[35]  G. Moore Cultured human lymphocytes , 1972, Journal of surgical oncology.

[36]  M. Greaves,et al.  Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. , 1971, Clinical and experimental immunology.

[37]  T. Campbell,et al.  A kinetic approach to a study of the induction of rat liver microsomal hydroxylase after pretreatment with 3,4-benzpyrene and aflatoxin B 1 . , 1970, Biochemical pharmacology.

[38]  A. Conney,et al.  Cigarette Smoking: Stimulatory Effect on Metabolism of 3,4-Benzpyrene by Enzymes in Human Placenta , 1968, Science.

[39]  R. Kuntzman,et al.  Differences in the kinetics of benzpyrene hydroxylation by hepatic drug-metabolizing enzymes from phenobarbital and 3-methylcholanthrene-treated rats. , 1968, Biochemical and biophysical research communications.

[40]  W. Levin,et al.  Studies on the induction of CO-binding pigments in liver microsomes by phenobarbital and 3-methylcholanthrene. , 1967, Biochemical and biophysical research communications.

[41]  A. Conney Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[42]  H. Gelboin Carcinogens, enzyme induction, and gene action. , 1967, Advances in cancer research.

[43]  L. Wattenberg,et al.  HISTOCHEMICAL DEMONSTRATION OF REDUCED PYRIDINE NUCLEOTIDE DEPENDENT POLYCYCLIC HYDROCARBON METABOLIZING SYSTEMS , 1962 .